555 related articles for article (PubMed ID: 18171482)
1. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
Sha D; He YJ
Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
Zhao GG; Xiang XJ; He YJ
Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma.
Pan J; Kong L; Lin S; Chen G; Chen Q; Lu JJ
Laryngoscope; 2008 Nov; 118(11):1970-5. PubMed ID: 18758376
[TBL] [Abstract][Full Text] [Related]
6. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of vascular endothelial growth factor in nasopharyngeal carcinoma].
Zhao SP; Wang CL
Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):114-6. PubMed ID: 12934350
[TBL] [Abstract][Full Text] [Related]
8. Elevation of vascular endothelial growth factor in Indonesian advanced stage nasopharyngeal carcinoma.
Kurnianda J; Hardianti MS; Harijadi ; Taroeno-Hariadi KW; Purwanto I; Haryana SM; Tjokronagoro MS
Kobe J Med Sci; 2009 Jun; 55(2):E36-44. PubMed ID: 20847590
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between VEGF-C expression and nasopharyngeal carcinoma proliferation and metastasis].
Shi XY; Hu GQ; Yuan XL; Li HY; Liu YQ; Ma D
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):364-7. PubMed ID: 17045002
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
11. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas.
Zhang Y; Huang D; Yu G
Acta Otolaryngol; 2005 Dec; 125(12):1345-50. PubMed ID: 16303685
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of endothelin A receptor expression to prognosis of nasopharyngeal carcinoma].
Mai HQ; Zeng ZY; Zhang HZ; Hou JH; Mo HY; Guo X; Min HQ; Hong MH
Ai Zheng; 2005 May; 24(5):611-5. PubMed ID: 15890108
[TBL] [Abstract][Full Text] [Related]
13. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
14. [Expression of vascular endothelial growth factor and nm23 as prognostic factors in nasopharyngeal carcinoma].
Zhang G; Zeng J; Gong L; Wu G; Zhou Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):372-5. PubMed ID: 12761948
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of Fas-ligand expression in nasopharyngeal carcinoma.
Ho SY; Guo HR; Chen HH; Hsiao JR; Jin YT; Tsai ST
Head Neck; 2004 Nov; 26(11):977-83. PubMed ID: 15390195
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma--a prognostic evaluation and correlation with hypoxia inducible factor 1alpha and vascular endothelial growth factor.
Chan CM; Ma BB; Hui EP; Wong SC; Mo FK; Leung SF; Kam MK; Chan AT
Oral Oncol; 2007 Apr; 43(4):373-8. PubMed ID: 16979927
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of vascular endothelial growth factor detection in forecasting distant metastasis risk of nasopharyngeal carcinoma].
Guo X; Cao SM; Hong MH; Zhang CQ; Han AJ; Xiang YQ; Hou JH; Min HQ
Ai Zheng; 2004 Oct; 23(10):1171-5. PubMed ID: 15473929
[TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
[TBL] [Abstract][Full Text] [Related]
19. Co-elevated expression of hepatocyte growth factor and Interleukin-8 contributes to poor prognosis of patients with primary nasopharyngeal carcinoma.
Xie LQ; Bian LJ; Li Z; Li Y; Liang YJ
Oncol Rep; 2010 Jan; 23(1):141-50. PubMed ID: 19956874
[TBL] [Abstract][Full Text] [Related]
20. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis.
Li Z; Bian LJ; Li Y; Liang YJ; Liang HZ
Pathol Res Pract; 2009; 205(8):542-50. PubMed ID: 19269113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]